Register for only $199 ($499 usual) before :
The drug development model is in need of a drastic shakeup. And COVID-19 has only accelerated this. With lengthy and costly approval processes, generic incursion, rising development costs and the need for novel adherence strategies, pharma and biotech, now more than ever need to initiate innovative formulation, delivery and development approaches in order to improve bioavailability and therapeutic performance. We’re here to help.
The Virtual 2020 Global Drug Bioavailability Enhancement Summit will connect industry leaders from both small molecule and biologics areas to address challenges at the interface between drug discovery and preclinical/clinical development. 2020’s Summit will share cutting edge research on the development, characterization and manufacture of formulations that span multiple modalities. Hear from 30+ senior drug bioavailability pioneers and network with 100’s of senior drug development innovators and walk away with over 2 years of new drug formulation and bioavailability enhancement approaches strategies in just 2 days!
Are you looking to improve drug performance, bioavailability and patient adherence? Would you like to reduce dosage, cost and time-to-market? Secure your virtual ticket today!
NEED HELP CONVINCING YOUR BOSS?
Let us help by generating you a custom message for you to send to your boss. Email it, talk them through it in person, tweet it to them 280 characters at a time: up to you.
- Precision medicine & healthcare delivery
- Rationale formulation design for poorly soluble compounds
- In-vivo – in-vitro correlation
- Solution behavior of amorphous solid dispersions
- Nanosuspension for improving the bioavailability
- Early formulation screening in drug discovery
- 3D printing for biopharmaceuticals
- Enhancing patient adherence via drug delivery
- Innovative strategies around drug / device combinations
of Senior Participants
December’s Speakers Include:
Sudhakar Garad, PhD
Global Head of Chemical and Pharmaceutical Profiling
Fady Ibrahim, PhD
Team Leader, Senior Principal Scientist
Sune Anderson, PhD
Principal Scientist, Spray Drying
Johnson & Johnson
Tycho Speaker, PhD
Director, Drug Delivery and Biomaterials, Abbvie
Rick Panicucci, PhD
Senior Vice President, CMC
Rakesh Dixit, PhD
President & CEO
Hamsini Dhoolypala, PhD
Senior Associate Scientist, Bioanalytical Methods
Ajit Narang, PhD
Senior Associate Scientist
Piotr Grodzinski, PhD
Director, NCI Office of Cancer Nanotechnology Research
NCI / NIH
Binfeng Xia, PhD
Senior Manager, Analytical Chemistry, Sanofi
Xiaoling Li, PhD
Associate Dean, Professor & Co-Founder
Phillip Snyder, PhD
Associate Director, Preclinical and Pharmaceutical Sciences
2020 Sponsors & Exhibitors
Register Before October 23, 2020
Register Before Nov 24, 2020
Register Nov 25, 2020 Onwards
Drug delivery strategy plays a major role within the future potential success of your product. Whether nurturing a new compound or developing a line of generic products, choosing the most effective delivery strategy can open the door to both opportunities, and...
Historically, oral administration has been considered the easiest and most convenient method of drug delivery, as it requires minimal expertise and invasiveness. Although oral delivery works fairly effectively for small-molecule drug products, oral delivery of...
It’s no lie the drug development model is in need of a drastic shakeup. With lengthy and costly approval processes, generic incursion, rising development costs and the need for novel adherence strategies, pharma and biotech, now more than ever need to initiate...
Subscribe and receive free pharma R & D strategies, podcast episodes, tips and weekly resources directly from Curtis & Coulter to your inbox